Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - AU
The Guardian - AU
National
Melissa Davey and Tom McIlroy

Life-changing MS drugs to stay on the PBS. So why are others under threat – and how is Trump involved?

A customer waits at a pharmacy counter in Canberra
The federal government says key drugs for multiple sclerosis will continue to receive taxpayer subsidies. It comes after pharmaceutical companies have pulled some drugs from the PBS in recent months. Photograph: AAP

Australians living with multiple sclerosis will continue receiving cheaper access to life-changing medical treatments, after an expert advisory panel decided to maintain taxpayer subsidies for key drugs.

The health minister, Mark Butler, confirmed on Thursday that the drugs – Ocrevus, Kesimpta and Lemtrada – would not be removed from the Pharmaceutical Benefits Scheme, ending uncertainty as manufacturers pushed the government not to reduce the price they paid for drugs.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.